Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma
Authors
Stephan Spahn 1, Daniel Roessler 2, Radu Pompilia 3 4, Gisela Gabernet 5, Beryl Primrose Gladstone 1, Marius Horger 6, Saskia Biskup 7, Magdalena Feldhahn 7 , Sven Nahnsen 5, Franz J Hilke 8 9, Bernhard Scheiner 10, Jean-François Dufour 3 4, Enrico N De Toni 2, Matthias Pinter 10, Nisar P Malek 1 11, Michael Bitzer 1 11
- Department Internal Medicine I, Eberhard-Karls University, 72076 Tuebingen, Germany.
- Department of Medicine II, University Hospital Ludwig-Maximilians-University (LMU), 81377 Munich, Germany.
- Hepatology-Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland.
- University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern, 3010 Bern, Switzerland.
- Quantitative Biology Center (QBiC), Eberhard-Karls University, 72076 Tuebingen, Germany.
- Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, 72076 Tuebingen, Germany.
- CeGaT GmbH and Praxis für Humangenetik, 72076 Tuebingen, Germany.
- Institute of Medical Genetics and Applied Genomics, Eberhard-Karls University, 72076 Tuebingen, Germany.
- Department of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
- Center for Personalized Medicine, Eberhard-Karls University, 72076 Tuebingen, Germany.